Latest news
AGIO Maintained by JP Morgan -- Price Target Raised to $34 - GuruFocusGuruFocus · Fri, 07 Aug 2026 16:47:42 GMTAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agios Pharma (AGIO), Novavax (NVAX) and Keros Therapeutics (KROS) - theglobeandmail.comtheglobeandmail.com · Wed, 05 Aug 2026 05:38:00 GMTAgios: Buy Rating Reiterated on Strong AQVESME Uptake and Pipeline Progress, Price Target Maintained at $46 - TipRanksTipRanks · Sun, 02 Aug 2026 14:40:05 GMTAGIO Maintained by Citigroup -- Price Target Raised to $52.00 - GuruFocusGuruFocus · Fri, 31 Jul 2026 23:12:14 GMTTruist Financial Maintains Agios Pharmaceuticals(AGIO.US) With Buy Rating, Announces Target Price $39 - MoomooMoomoo · Fri, 31 Jul 2026 13:36:00 GMTAgios Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 30 Jul 2026 14:04:28 GMTAGIO: Q2 2026 revenue tripled year-over-year, fueled by AQVESME launch and robust pipeline progress - TradingViewTradingView · Thu, 30 Jul 2026 11:14:15 GMT